QUINCE THERAPEUTICS INC
QNCXNASDAQ🏆 #3572 by market capEarnings Nov 10US Equity
$32.82▲ $2.01 (+6.13%)
Market closed · at close1h—
24h▲ 6.1%
7d▲ 14.6%
14d▲ 49.3%
30d▲ 87.5%
1y▼ 91.1%
🏦Market Cap
$32M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
66
Fair
📊
Analyst Ratings
Price
$32.82
Total
10
Raised
0
Lowered
6
| Institution | Action | Rating | Date |
|---|---|---|---|
Oppenheimer | Reiterated | Outperform | 2026-07-29 |
Citizens | Downgraded | Market Outperform → Market Perform | 2026-01-30 |
D. Boral Capital | Downgraded | Buy → Hold | 2026-01-30 |
JMP Securities | Reiterated | Market Outperform | 2025-08-12 |
Credit Suisse | Reiterated | Underperform | 2022-05-10 |
HC Wainwright & Co. | Reiterated | Buy | 2022-03-08 |
Canaccord Genuity | Downgraded | Buy → Hold | 2022-01-27 |
B of A Securities | Downgraded | Neutral → Underperform | 2021-10-26 |
Jefferies | Downgraded | Buy → Hold | 2021-02-16 |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2013-09-16 |
One row per institution, most recent rating